Sep 2026
B-Cell Lymphomas, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology.
Pirtobrutinib and CAR T-cell therapy and CAR T-cell therapy have emerged as effective treatment options for refractory or progressive disease after prior treatment with covalent BTK inhibitors.
A. Zelenetz, Leo I. Gordon, Jeremy S. Abramson et al.
· The Journal of the National... · 0 citations